| GeneLibs

题目:: Polymorphisms of the coagulation system and risk of cancer.
作者:: Tinholt(Mari),Sandset(Per Morten),Iversen(Nina)
状态:: 发布时间2016-04-12 , 更新时间 2016-04-12
期刊:: Thromb Res
摘要:: Hypercoagulability is a frequently finding in patients with cancer, and is associated with an increased risk of venous thrombosis (VT). Cancer-associated VT is associated with poor prognosis and represents the leading non-cancer cause of death among these patients. Conversely, patients experiencing VT are at increased risk of subsequent cancer, suggesting an epidemiological bidirectional link between cancer and hemostasis, and indicating a role of the hemostatic system in cancer development. How the coagulation system relates to cancer etiology at the genetic level is largely unexplored. Data on the association of polymorphisms in genes involved in coagulation with cancer development is important to clarify the role of the coagulation system in cancer pathogenesis. Effects of coagulation-related gene polymorphisms on cancer risk may possibly be translated into novel treatment- and prevention strategies of cancer-associated thrombosis and the cancer itself. This article reviews the current knowledge of the relation between polymorphisms in genes involved in coagulation and cancer risk in solid tumors.
语言:: eng
DOI:: 10.1016/S0049-3848(16)30098-6

文献库文献相关信息